Persistent hypercalcitoninemia in patients with medullary thyroid cancer

Tumori

Volumn 95, Issue 4, 2009, Pages 484-487

  Misso, Claudia ^a   Calzolari, Filippo ^a   Puxeddu, Efisio ^a   Lucchini, Roberta ^a   Monacelli, Massimo ^a   Giammartino, Camillo ^a   Sanguinetti, Alessandro ^a   D'Ajello, Michele ^a   Ragusa, Mark ^a   Avenia, Nicola ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Calcitonin; Medullary thyroid carcinoma; Surgical strategy

Indexed keywords

CALCITONIN;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ARTICLE; CALCITONIN BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; LAPAROSCOPY; LIVER DISEASE; LIVER METASTASIS; LYMPHADENECTOMY; MALE; NECK DISSECTION; PERITONEAL DISEASE; PERSISTENT HYPERCALCITONEMIA; RECURRENT DISEASE; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 70350056221     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160909500413     Document Type: Article

References (22)

1. Pelizzo MR, Bernante P, Piotto A, Toniato A, Girelli ME, Busnardo E, Rupolo M, Fassina A, Pennelli N: The extent of surgery for thyroid medullary cancer. Tumori, 80: 427-432, 1994.
2. Gimm O, Ukkat J, Dralle H: Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma. World J Surg, 22: 562-567, 1998. (Pubitemid 28215433)
3. Murat A: Detection of residual lesions and metastases of medullary thyroid cancer. Ann Endocrinol (Paris), 57: 27-32, 1996.
4. Machens A, Schneyer U, Holzhausen HJ, Dralle H: Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. J Clin Endocrinol Metab, 90: 2029-2034, 2005. (Pubitemid 40586235)
5. Favia G, Iacobone M: Medullary thyroid carcinoma: state of the art. G Chir, 26: 405-409, 2005.
6. Roman S, Lin R, Sosa JA: Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer, 107(9): 2134-2142, 2006. (Pubitemid 44665646)
7. Guben K, Berberoglu U, Boyabatli M: Prognostic factor for sporadic medullary thyroid carcinoma. World J Surg, 30: 84-90, 2006. (Pubitemid 43081618)
8. Van Heerden JA, Grant CS, Gharib H, Hay ID, Ilstrup DM: Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg, 212: 395-401, 1990. (Pubitemid 20369771)
9. Kebebew E, Ituarte PH, Siperstein A E, Duh QY, Clark OH: Medullary thyroid carcinoma. Clinical characteristics, treatment, prognostic factors, and a comparison of staging system. Cancer, 88: 1139-1148, 2000.
10. Gimm O, Heyn V, Krause U, Sekulle C, Ukkat J, Dralle H: Prognostic significance of disseminated tumor cells in the connective tissue of patients with medullary thyroid carcinoma. World J Surg, 30: 847-852, 2006. (Pubitemid 43724116)
11. Moley JF, Wells SA, Dilley WG, Tisell LE: Reoperation for recurrent or persistent medullary thyroid cancer. Surgery, 114: 1090-1095, 1993.
12. Kebebew E, Kikuchi S, Duh QY, Clark OH: Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid. Arch Surg, 135: 895-901, 2000. (Pubitemid 30625965)
13. Thyroid carcinoma: National Comprehensive Cancer Network Guidelines 2005.
14. Kendall-Taylor P, Working Group: Guidelines for the management of thyroid cancer. Clin Endocrinol, 58: 400-402, 2003. (Pubitemid 36390609)
15. Harris PE: The management of thyroid cancer in adults: a review of new guidelines. Clin Med, 2: 144-146, 2002.
16. Proye C: Medullary thyroid carcinomas: persistent hypercalcitoninemia after surgery, reoperation - results. Ann Chir, 128: 289-292, 2003.
17. Tisell LE, Dilley WG, Wells SA Jr: Progression of postoperative residual medullary thyroid carcinoma as monitored by plasma calcitonin levels. Surgery, 119: 34-39, 1996.
18. Dralle H, Damm I Scheumann GF, Kotzerke J, Kupsche E, Geerlings H, Pichlmayr R: Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today, 87: 112-121, 1994. (Pubitemid 24081294)
19. Hamy A, Pessaux P, Mirallie E, Mcci-Hennekinne S, Gibelin H, Mor-Martinez C., de Calan L, Ronceray J, Kraimps JL: Central neck dissection in the management of sporadic medullary thyroid microcarcinoma. Eur J Surg Oncol, 31: 774-777, 2005. (Pubitemid 41194656)
20. Bhur HJ, Kallinowski F, Raue F, Frank-Raue K, Herfarth C: Microsurgical neck dissection for occultly metastasizing medullary thyroid carcinoma: three-year results. Cancer, 72: 3685-3693, 1993. (Pubitemid 24000605)
21. Medina-Franco H, Herrera MF, Lopez G, Tielve-Campillo M, Sierra M, Lozano-Salazar RR, Gonzalez O: Persistent hypercalcitoninemia in patients with medullary thyroid cancer: a therapeutic approach based on selective venous sampling for calcitonin. Rev Invest Clin, 53: 212-217, 2001. (Pubitemid 33679080)
22. Franc S, Niccoli-Sire P, Cohen R, Bardet S, Maes B, Murat A, Krivitzky A, Modigliani, French Medullary Study Group (GETC): Complete surgical lymph node resection does prevent authentic recurrences of medullary thyroid carcinoma. Clin Endocrinol (Oxford), 55: 403-409, 2001.